Brief: Q BioMed Announces Updates On Commercialization Of Non-Opioid Metastatic Cancer Pain Drug
11/07/2019 13:54
July 11 (Reuters) - Q BioMed Inc QBIO.PK :
* Q BIOMED ANNOUNCES UPDATES ON COMMERCIALIZATION OF
NON-OPIOID
METASTATIC CANCER PAIN DRUG
* Q BIOMED INC - REMAIN CONFIDENT IN BRINGING A STRONTIUM-89
PRODUCT TO MARKET THIS YEAR
* Q BIOMED INC - CONTRACT MANUFACTURER EXPECTS TO COMPLETE
FINAL
SITE MODIFICATIONS TO CANCER PAIN DRUG AFTER ITS RECENT
INSPECTION BY END OF MONTH
* Q BIOMED INC SAYS EXPECTS FDA APPROVAL OF ISOTHERAPEUTICS
TO
PRODUCE A COMMERCIAL DRUG PRODUCT TO POSITIVELY IMPACT OUR
BUSINESS OVER NEXT FEW MONTHS
Source text for Eikon: ID:nGNXbYKd6x
Further company coverage: QBIO.PK
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B